Bangladesh doctors claim to have found effective drug combination to cure COVID-19 patients

[Tom-tom]

Bangladesh doctors claim to have found effective drug combination to cure COVID-19 patients

Cure for coronavirus Photograph Reuter
May 17, 2020, 06.13 PM (IST)
A Bangladeshi medical team has claimed their research on the combination of two widely used drugs has yielded "astounding" results in curing the patients with acute symptoms of the novel coronavirus.

The global pandemic has claimed the lives of over 3,12,000 people across the world.

The claim by the Bangladeshi medical team comes amidst the desperate global attempts for a remedy to the deadly coronavirus.


Out of 60 COVID-19 patients, all recovered as the combination of the two drugs were applied, Professor Dr Md Tarek Alam, the head of medicine department at private Bangladesh Medical College Hospital (BMCH), claimed.

According to the research, a frequently used antiprotozoal medicine called Ivermectin in a single dose with Doxycycline, an antibiotic, yielded virtually the near-miraculous result in curing the patients with COVID-19.

Bangladesh has so far reported 20,995 coronavirus cases and 314 deaths.

The coronavirus, which broke out initially in China, has claimed the lives of 3,12,115 people while infected over 46,50,793, according to Johns Hopkins University.
https://www-wionews-com.cdn.ampproj...-combination-to-cure-covid-19-patients-299247

 

[litman]

the name ivemectin also came up in an australian study.

 

[Indos]

Yup, only the present drug that can help cure the Covid patient in this year, new drug which is researched specifically for the disease need at east next year to be mass produced. I hope that medical doctors are honest and not part of the marketing team of the drug. I know there is some kind of unethical connection between some doctors and drug makers.

 

[Abu Shaleh Rumi]

How can an anti biotic drug can help curing viral disease?

 

[Nilgiri]

How can an anti biotic drug can help curing viral disease?

It is very dependent sometimes on specific area and what the main symptom load is like for a particular population (w.r.t general underlying conditions that corona targets most)...and even specific patients. Though this is of course still ongoing study for most part.

Examples can be the effect of antibiotic/protozoa medicine action on existing disease load (esp active or lingering in inflammed spots that corona symptoms make), so the body has more resource naturally to fight the corona itself.

Another can be their secondary or tertiary characteristics (mechanisms of which are sometimes still not understood, but the data from trials has long been established) playing their role in specific mechanisms that corona creates among the most sensitive to it.

Like how HCQ (anti-malarial) is also found to have immuno-suppresion tendency (and since long been used to help with things like arthiritis and lupus in some cases)....and this is actually something that can help some patients too, given the "cytokine storm" (hyper active immune system response that creates the terrible symptom of lung inflammation that ends up taking most lives in the end rather than corona directly itself).

@bluesky @leonblack08 @mmr @Vergennes

 

[Foxtrot Delta]

Well i hope it is true.

 

[mmr]

It is very dependent sometimes on specific area and what the main symptom load is like for a particular population (w.r.t general underlying conditions that corona targets most)...and even specific patients. Though this is of course still ongoing study for most part.

Examples can be the effect of antibiotic/protozoa medicine action on existing disease load (esp active or lingering in inflammed spots that corona symptoms make), so the body has more resource naturally to fight the corona itself.

Another can be their secondary or tertiary characteristics (mechanisms of which are sometimes still not understood, but the data from trials has long been established) playing their role in specific mechanisms that corona creates among the most sensitive to it.

Like how HCQ (anti-malarial) is also found to have immuno-suppresion tendency (and since long been used to help with things like arthiritis and lupus in some cases)....and this is actually something that can help some patients too, given the "cytokine storm" (hyper active immune system response that creates the terrible symptom of lung inflammation that ends up taking most lives in the end rather than corona directly itself).

@bluesky @leonblack08 @mmr @Vergennes

Every day we are learning new things. I have very limited knowledge on this. Just hope one of the vacancies work by the end of this year.

Otherwise south asia has to go through herb immunity no other practical choice if it continues till 2021.

 

[Avicenna]

Every day we are learning new things. I have very limited knowledge on this. Just hope one of the vacancies work by the end of this year.

Otherwise south asia has to go through herb immunity no other practical choice if it continues till 2021.

I would think people would wanna avoid herb immunity.

 

[Michael Corleone]

@Avicenna I don’t have my degree and barely made through pharmacology last year. How’s antibiotics having antiviral actions? Wtf

Every day we are learning new things. I have very limited knowledge on this. Just hope one of the vacancies work by the end of this year.

Otherwise south asia has to go through herb immunity no other practical choice if it continues till 2021.

Vaccines need to be approved and if we’re to follow normal process than wait 16 years for it. COVID is to be a seasonal thing from now on I reckon, until it dies out like the Spanish flu

 

[Avicenna]

@Avicenna I don’t have my degree and barely made through pharmacology last year. How’s antibiotics having antiviral actions? Wtf


Vaccines need to be approved and if we’re to follow normal process than wait 16 years for it. COVID is to be a seasonal thing from now on I reckon, until it dies out like the Spanish flu

Drugs sometimes have clinically significant secondary effects not associated with its main use.

https://www.sciencedirect.com/science/article/pii/S0166354220302011

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/

Maybe there is something to this story.

I hope so at least.

But back to reality....

https://www.news-medical.net/news/20200427/Ivermectin-alone-not-useful-in-treating-COVID-19.aspx

 

[mmr]

I would think people would wanna avoid herb immunity.

If not then we need universal basic income. No other choice or people will die out of hunger. And i am not taking about just bd.

USA and Canada should introduce universal basis income as well.

Covet 19 teach us one thing. Big government is not always bad.

 

[bluesky]

the name ivemectin also came up in an australian study.

Hope, the following news will also interest you. If this ivermectin is already being used in America, Japan and Australia, how come BD doctors claim they are the pioneer? The news below was published in April 25 2020 and all these countries have not ever said that this medicine is 100 percent effective.

People should be more serious instead of talking cheap.

https://mainichi.jp/english/articles/20200425/p2a/00m/0na/007000c

Antiparasitic drug ivermectin reduces coronavirus fatality rate: American researchers


April 25, 2020 (Mainichi Japan)

Japanese version




Tablets of ivermectin, or Mectizan by trade name, are seen in this photo provided by MSD.



Kitasato University distinguished emeritus professor Satoshi Omura is seen in this August 2014 file photo. (Mainichi/Yohei Koide)
TOKYO -- An American research team has reported that ivermectin, a medication used to treat head lice and other parasitic infestations, is effective in reducing the mortality rate of the novel coronavirus.

• 【Related】Japan lists 10,000 clinics offering telemedicine for new patients
• 【Related】Online dental examinations approved in Japan amid coronavirus fears
• 【Related】Japan to ask virus carriers with mild or no symptoms to use medical-equipped lodgings

According to the team, the death rate of coronavirus patients declined to about one-sixth, compared to the rate of death in those who did not use the medication.

The medication was developed based on substances produced by bacteria, discovered by Kitasato University distinguished emeritus professor Satoshi Omura, winner of the 2015 Nobel Prize in physiology or medicine. It has been used to treat onchocerciasis, a disease caused by parasites with symptoms including blindness, and lymphatic filariasis, a parasitic disease that can cause thickening of the skin.

An Australian research team had initially confirmed in experiments on cells that ivermectin is effective in reducing the amount of novel coronavirus molecules. The team says a dose of the treatment suppressed virus growth within one or two days of administration.

The American team collected data of coronavirus patients who received some kind of treatment between January and March 2020. Researchers carried out statistical analysis by comparing 704 cases in which patients were administered with ivermectin at 169 medical institutions in Asia, Europe and North America to 704 cases in which the medication was not used.

Of the patients who had to use ventilators, the death rate of patients who were not treated with ivermectin stood at 21.3%, while the figure for those who received the medication stood at 7.3% -- about one-third of the former figure. Furthermore, the mortality rate of all patients stood at 1.4% for those who were administered ivermectin. This was roughly one-sixth of the death rate for people who did not use the medication, which stood at 8.5%.

The team says the use of ivermectin is also effective in shortening the days a patient needs to be hospitalized, serving as a point of reference when considering treatment methods.